BLMH/Bleomycin Hydrolase Products

Description

Bleomycin hydrolase (BMH) is a cytoplasmic cysteine peptidase that is highly conserved through evolution; however, the only known activity of the enzyme is metabolic inactivation of the glycopeptide bleomycin (BLM), an essential component of combination chemotherapy regimens for cancer. The protein contains the signature active site residues of the cysteine protease papain superfamily. [provided by RefSeq]

Bioinformatics

Entrez	642 Human
Uniprot	NM_000386 Human NP_000377 Human NP_000377.1 Human Q13867 Human
Product By Gene ID	642
Alternate Names	BHBMHBLM hydrolase bleomycin hydrolase EC 3.4.22.40

Research Areas for BLMH/Bleomycin Hydrolase

Find related products by research area and learn more about each of the different research areas below.

Cancer
DNA Repair
Genes Sensitive to DNA Damaging Agents